AUTH/2695/1/14: Member of the public v Sanofi (Lyxumia) — outwith scope, no breach | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/2695/1/14
Complainant	Member of the public
Company	Sanofi
Product / topic	Clinical Trial Disclosure (Lyxumia)
Complaint received	16 January 2014
Completed	12 March 2015
Applicable Code year	2012
Decision	No breach; outwith the scope of the Code
Case report	No case report (outwith scope)
Additional sanctions	Not stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

A member of the public made a complaint to the PMCPA about clinical trial disclosure relating to Lyxumia.
The matter was reviewed under the ABPI Code of Practice (applicable Code year: 2012).

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →